Article info

Download PDFPDF
Reply to: Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a western population

Authors

  • Eva Doorakkers Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Jesper Lagergren Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden Division of Cancer Studies, King’s College London, London, UK PubMed articlesGoogle scholar articles
  • Lars Engstrand Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden Sciencefor Life Laboratory (SciLifeLab), Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Nele Brusselaers Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden Sciencefor Life Laboratory (SciLifeLab), Stockholm, Sweden Ghent University, Ghent, Belgium PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Nele Brusselaers, Department of Molecular Medicine and Surgery, Centre for Translational Microbiome Research, Karolinska Institutet, Stockholm 17176, Sweden; nele.brusselaers{at}ki.se
View Full Text

Citation

Doorakkers E, Lagergren J, Engstrand L, et al
Reply to: Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a western population

Publication history

  • Received April 29, 2019
  • Accepted May 8, 2019
  • First published May 21, 2019.
Online issue publication 
May 07, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.